These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 36192502)

  • 1. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
    Tan SK; Hougen HY; Merchan JR; Gonzalgo ML; Welford SM
    Nat Rev Urol; 2023 Jan; 20(1):48-60. PubMed ID: 36192502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
    Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
    Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression.
    Zhou L; Luo Y; Liu Y; Zeng Y; Tong J; Li M; Hou Y; Du K; Qi Y; Pan W; Liu Y; Wang R; Tian F; Gu C; Chen K
    Cancer Res; 2023 Dec; 83(23):3920-3939. PubMed ID: 37729394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
    Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
    Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid in Renal Carcinoma: Queen Bee to Target?
    Tan SK; Welford SM
    Trends Cancer; 2020 Jun; 6(6):448-450. PubMed ID: 32459999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
    Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
    Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma.
    Miess H; Dankworth B; Gouw AM; Rosenfeldt M; Schmitz W; Jiang M; Saunders B; Howell M; Downward J; Felsher DW; Peck B; Schulze A
    Oncogene; 2018 Oct; 37(40):5435-5450. PubMed ID: 29872221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
    Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
    J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
    Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
    Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming of clear cell renal cell carcinoma.
    Zhu H; Wang X; Lu S; Ou K
    Front Endocrinol (Lausanne); 2023; 14():1195500. PubMed ID: 37347113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting lipid metabolism in the treatment of ovarian cancer.
    Chaudhry S; Thomas SN; Simmons GE
    Oncotarget; 2022; 13():768-783. PubMed ID: 35634242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC.
    Ganner A; Philipp A; Lagies S; Wingendorf L; Wang L; Pilz F; Welte T; Grand K; Lienkamp SS; Klein M; Kammerer B; Frew IJ; Walz G; Neumann-Haefelin E
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.
    Du W; Zhang L; Brett-Morris A; Aguila B; Kerner J; Hoppel CL; Puchowicz M; Serra D; Herrero L; Rini BI; Campbell S; Welford SM
    Nat Commun; 2017 Nov; 8(1):1769. PubMed ID: 29176561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression.
    Wang S; Wang K; Yue D; Yang X; Pan X; Kong F; Zhao R; Bie Q; Tian D; Zhu S; He B; Bin Z
    Br J Cancer; 2024 Sep; 131(4):641-654. PubMed ID: 38906969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma.
    Wang D; Mahmud I; Thakur VS; Tan SK; Isom DG; Lombard DB; Gonzalgo ML; Kryvenko ON; Lorenzi PL; Tcheuyap VT; Brugarolas J; Welford SM
    Cancer Res; 2024 Jul; 84(13):2141-2154. PubMed ID: 38640229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
    Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
    Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
    Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
    Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
    Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.